MTOR and Parkinson disease: The activation of the Akt/mTOR pathway by agents was shown to restore the activity of mTOR, p70S6K, and 4E-BP1 in mouse models of PD, which alleviated apoptosis and ∂-synuclein levels in the SN [7–9].